"Marshfield Clinic Wausau Center is a major health care facility with more than 100 providers. In addition to primary care services, the Center offers a number of specialists who focus on treating more complicated health concerns. Cancer care is a top priority at the Wausau Center as witnessed by its accreditation by the National Accreditation Program for Breast Center (NAPBC), administered by the American College of Surgeons."

During the past decade, Marshfield Clinic-Wausau Center conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 89 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 49 clinical trials were completed. i.e. 222.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Clinic-Wausau Center" #1 sponsor was "National Cancer Institute (NCI)" with 70 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "Eastern Cooperative Oncology Group" with 18 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Clinic-Wausau Center" #1 collaborator was "National Cancer Institute (NCI)" with 113 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Clinic-Wausau Center" are "Breast Cancer" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Lymphoma" (6 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (6 trials). Many other conditions were trialed in "Marshfield Clinic-Wausau Center" in a lesser frequency.

Most popular intervention types in "Marshfield Clinic-Wausau Center" are "Drug" (137 trials), "Other" (112 trials), "Biological" (73 trials), "Procedure" (41 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (41 trials), "Questionnaire Administration" (22 trials), "Biospecimen Collection" (17 trials) and "Nivolumab" (16 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Clinic-Wausau Center" are 149 trials for "All" genders, 31 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Clinic-Wausau Center". undefined are not yet recruiting, 30 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Marshfield Clinic-Wausau Center, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Clinic-Wausau Center, 6 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".